Bklyn CBD CHILL TIME DROPS - 1800MG

Capture1.JPG
Capture1.JPG

Bklyn CBD CHILL TIME DROPS - 1800MG

$128.00

BKLYN CBD Chill Time Drops have been skillfully crafted to promote a sense of calmness and are our go-to for taking the edge off*. Made from organic U.S. grown hemp, our drops contains all of the plant's terpenes and cannabinoids to create a full spectrum blend.

Shake well. Take the oil sublingually, wait 20 seconds and swallow. One dropper delivers 60mg of CBD. Take additional droppers for the unwinding effect you desire. 

  • 60mg CBD / 1ml

  • 30ml bottle with 1800mg of CBD Oil

  • Non-psychoactive CBD made from organic U.S. hemp

  • All natural, contains no artificial flavors or coloring

  • Organic, vegan, gluten free, alcohol free and sugar free

Need to know: If you don't feel anything at first, be patient. Just like when you start taking a new supplement or regimen, it takes time to feel the full effects. Stay consistent. The results are cumulative and oftentimes subtle at first. 

Ingredients: Whole plant hemp extract (CBD), MCT Oil (fractionated coconut oil), natural raw hemp oil, organic sunflower lecithin.

Suggested Dosage: Start small with 1/2 dropper. It's generally recommended to start small and work your way up.

If your employment requires a drug test, please talk to your employer or physician first. Contains less than 0.3% THC.

Keep out of reach of children. Consult your doctor before taking if you are pregnant or nursing, have a medical condition, or take pharmaceutical drugs.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any diseases.

Quantity:
Add To Cart

WHY CBD?

CBD THERAPEUTIC BENEFITS

The World Health Organization published a report on CBD in November of 2017. Below is an overview in which CBD may have therapeutic benefits

Disease

Effects

Alzheimer's disease

Antinflammatory, antioxidant, antiapoptotic in in vitro and in vivo models
of Aβ-evoked neuroinflammatory and neurodegenerative responses.

Parkinson's disease

Attenuation of the dopaminergic impairment in vivo; neuroprotection; improvement of psychiatric rating and reduction of agitation, nightmare
and aggressive behaviour in patients.

Multiple sclerosis

Improved signs of EAE in mice, antinflammatory and immunomodulatory
properties.

Huntington's
disease

Neuroprotective and antioxidant in mice transgenic models; no significant
clinically important differences in patients.

Hypoxia-ischemia
injury

Short term neuroprotective effects; inhibition of excitotoxicity, oxidative
stress and inflammation in vitro and in rodent models.

Pain

Analgesic effect in patients with neuropathic pain resistant to other
treatments.

Psychosis

Attenuation of the behavioural and glial changes in animal models of
schizophrenia; anti-psychotic properties on ketamine-induced symptoms

Anxiety

Reduction of muscular tension, restlessness, fatigue, problems in concentration, improvement of social interactions in rodent models of
anxiety and stress; reduced social anxiety in patients.

Depression

Anti-depressant effect in genetic rodent model of depression.

Cancer

Antiproliferative and anti-invasive actions in a large range of cancer types;
induction of autophagy-mediated cancer cell death; chemopreventive effects.

Nausea

Suppression of nausea and conditioned gaping in rats

Inflammatory
diseases

Antinflammatory properties in several in vitro and in vivo models;
inhibition of inflammatory cytokines and pathways.

Rheumatoid
arthritis

Inhibition of TNF-α in an animal model

Infection

Activity against methicillin-resistant Staphylococcus aureus

Inflammatory bowel and Crohn's
diseases

Inhibition of macrophage recruitment and TNF-α secretion in vivo and ex vivo; reduction in disease activity index in Crohn's patients.

Cardiovascular
diseases

Reduced infarct size through anti-oxidant and anti-inflammatory
properties in vitro and in vivo.

Diabetic
complications

Attenuation of fibrosis and myocardial dysfunction